EXQUISOF
Live / Registered — Registered (as of 22 Nov 2022)
What this means for you
Registered since 22 Nov 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Nov 2028: the §8 declaration of use).
Record
- Serial number
- 97084182
- Registration number
- 6905441
- Mark type
- Word mark
- Filed
- 20 Oct 2021
- Published for opposition
- 06 Sept 2022
- Registered
- 22 Nov 2022
- Next maintenance filing
- §8 declaration of use, due by 22 Nov 2028 (grace period to 22 May 2029)
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Brentford, Middlesex, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
Prosecution history
- 22 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 09 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Nov 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Nov 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Sept 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Sept 2022 — PUBLISHED FOR OPPOSITION
- 17 Aug 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jul 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Jul 2022 — EXAMINER'S AMENDMENT ENTERED
- 29 Jul 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 29 Jul 2022 — EXAMINERS AMENDMENT E-MAILED
- 29 Jul 2022 — EXAMINERS AMENDMENT -WRITTEN
- 26 Jul 2022 — DATA MODIFICATION COMPLETED
- 26 Jul 2022 — ASSIGNED TO LIE